NASOPHARYNGEAL CARCINOMA
Clinical trials for NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early cancer drug trial halted after initial safety testing
Disease control TerminatedThis early-stage study tested a new drug called INCB099318 in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety, how the body processes it, and what side effects it might cause. The trial was termina…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Early trial halted for new cancer drug targeting multiple advanced cancers
Disease control TerminatedThis early-stage study tested a new drug called PRO1160 in 42 patients with advanced cancers that had spread or returned after previous treatments. The main goals were to find a safe dose and see if the drug could help control kidney cancer, nasopharyngeal cancer, or lymphoma. Th…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC